We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Rock Creek Pharmaceuticals Reports First Clinical Trial Showing Anatabloc(TM) Lowers Chronic Inflammation

News   Jan 31, 2012

 
Rock Creek Pharmaceuticals Reports First Clinical Trial Showing Anatabloc(TM) Lowers Chronic Inflammation
 
 
Advertisement
 

RELATED ARTICLES

Trial Investigates Remdesivir–Baricitinib Combo as COVID-19 Treatment

News

Following on from remdesivir’s promising results from previous studies, a new trial is now investigating remdesivir in combination with baricitinib or placebo as a treatment for COVID-19, in a double-blind, randomized trial.

READ MORE

Platinum-based Chemo May Improve Survival in Certain Metastatic Pancreatic Cancer Patients

News

Patients with metastatic pancreatic cancer who had germline or somatic mutations in DNA repair genes had better clinical outcomes after platinum-based chemotherapy, compared with patients that did not have these mutations, according to a new study.

READ MORE

Not Enough Women and Older Adults in Cholesterol Drug Trials, Study Suggests

News

Johns Hopkins Medicine researchers report that although some progress has been made — women and older adults are still underrepresented in lipid lowering therapy trials compared with their disease burden.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE